Max Viscontini
Impact in
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism
Papers in
-
- Metabolism and Genetic Disorders 51
- Biochemistry 43
- Amino Acid Enzymes and Metabolism 36
- Co-authors
- Paul Karrer (23 shared papers)Jost Hans Bieri (30 shared papers)Albert M. Bobst (5 shared papers)Ernst Hadorn (5 shared papers)Rudolf H. Weber (7 shared papers)Dominic G. Hoch (2 shared papers)Toshihiko Okada (5 shared papers)H.‐Ch. Curtius (5 shared papers)
- Journals
- Helvetica Chimica Acta (160 papers)Cellular and Molecular Life Sciences (2 papers)Advances in experimental medicine and biology (2 papers)The Lancet (1 paper)Die Naturwissenschaften (1 paper)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Max Viscontini
181 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Clinical Biochemistry 596
- Biochemistry 363
- Organic Chemistry 831
- Pharmaceutical Science 132
- Inorganic Chemistry 263
Countries citing papers authored by Max Viscontini
This map shows the geographic impact of Max Viscontini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Viscontini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Viscontini more than expected).
Fields of papers citing papers by Max Viscontini
This network shows the impact of papers produced by Max Viscontini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Viscontini. The network helps show where Max Viscontini may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Viscontini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1955 | 106 | |
| 2 | 1979 | 97 | |
| 3 | 1957 | 74 | |
| 4 | 1981 | 64 | |
| 5 | 1966 | 58 | |
| 6 | 1955 | 49 | |
| 7 | 1959 | 49 | |
| 8 | 1970 | 49 | |
| 9 | 1978 | 48 | |
| 10 | 1967 | 42 | |
| 11 | 1995 | 41 | |
| 12 | 1975 | 38 | |
| 13 | Excretion of pterins in phenylketonuria and phenylketonuria variants. | 1980 | 36 |
| 14 | 1952 | 33 | |
| 15 | 1956 | 32 | |
| 16 | 1977 | 31 | |
| 17 | 1966 | 29 | |
| 18 | 1965 | 29 | |
| 19 | 1951 | 27 | |
| 20 | 1955 | 27 |
About Max Viscontini
Max Viscontini is a scholar working on Clinical Biochemistry, Biochemistry, Organic Chemistry, Pharmaceutical Science and Inorganic Chemistry, having authored 182 papers that have together received 2.6k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (51 papers), Amino Acid Enzymes and Metabolism (36 papers), Chemical Synthesis and Analysis (18 papers), Carbohydrate Chemistry and Synthesis (16 papers), Synthesis and Catalytic Reactions (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers), Chemical Reactions and Isotopes (14 papers) and Coordination Chemistry and Organometallics (13 papers). The work is most often cited by research in Clinical Biochemistry (596 citations), Biochemistry (363 citations), Organic Chemistry (831 citations), Pharmaceutical Science (132 citations) and Inorganic Chemistry (263 citations). Max Viscontini has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include Paul Karrer, Jost Hans Bieri, Albert M. Bobst, Ernst Hadorn, Rudolf H. Weber, Dominic G. Hoch, Toshihiko Okada, H.‐Ch. Curtius, Alois Niederwieser and Eva Loeser. Their work appears in journals such as Helvetica Chimica Acta, Cellular and Molecular Life Sciences, Advances in experimental medicine and biology, The Lancet and Die Naturwissenschaften.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.